No Picture
News

MiLaboratories And MIODx Collaborate On Services And Product Development In TCR And BCR Repertoire Profiling

SAN DIEGO and SAN JOSE, Calif., Aug. 14, 2019 /PRNewswire/ — MiLaboratories LLC, a technology leader in T-cell receptor (TCR) and B-cell receptor (BCR) profiling and MIODx, a well-known immunosequencing specialist, announced today a collaboration a… […]

No Picture
News

Medical Marijuana, Inc. Subsidiary Kannaway® Enters Strategic Partnership With Endocanna Health to Create and Sell Endocannabinoid DNA Test Products

SAN DIEGO, Aug. 1, 2019 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first publicly traded cannabis company in the United States that launched the world’s preeminent cannabis-derived nutraceutical products, brands and su… […]

No Picture
News

Mirati Announces Clinical Collaboration to Evaluate MRTX849 in Combination with SHP2 Inhibitor TNO155

SAN DIEGO, July 9, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced a clinical collaboration agreement with Novartis to evaluate the combination of MRTX849, Mirati’s investiga… […]

No Picture
News

OncoSec Receives Exclusive Licensing Rights from Dana-Farber Cancer Institute to CAR T-Cell Therapies for the Treatment of Solid Tumor Cancers

Development Collaboration Will Initially Focus on CAR T-Cell Therapy for Triple-Negative Breast Cancer

SAN DIEGO and PENNINGTON, N.J., June 27, 2019 /PRNewswire/ — OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage… […]

No Picture
News

NYU Winthrop and Progenity Collaborate to Develop Diagnostic Test to Assess Risk for Preterm Birth

MINEOLA, N.Y. and SAN DIEGO, June 25, 2019 /PRNewswire/ — NYU Winthrop Hospital and Progenity, Inc., today announced a collaborative research and development initiative for women’s health with a focus on preterm births. As part of the init… […]

No Picture
News

German Federal Joint Committee (G-BA) Issues Exclusive Nationwide Reimbursement Decision for Oncotype DX Breast Recurrence Score® Test

Reimbursement Decision Follows IQWiG’s Recommendation Based on TAILORx Study Results

REDWOOD CITY, Calif., June 20, 2019 /PRNewswire/ — Genomic Health announced today that the German Federal Joint Committee (G-BA) issued a positive reimbursement dec… […]

No Picture
News

Inhibrx Announces Option Agreement for Development and Commercialization of INBRX-101 (AAT-Fc) Outside of the United States and Canada with Chiesi Group

– Up to $162.5M in upfront, cost sharing and milestone payments, and escalating royalties into the high teens assuming exercise of the option

SAN DIEGO, May 30, 2019 /PRNewswire/ — Inhibrx, Inc. (“Inhibrx”), a clinical-stage biotechnology company de… […]

No Picture
News

Trovagene Announces Research Collaboration with Nektar Therapeutics to Evaluate Efficacy of the Combination of Onvansertib and ONZEALD(TM) in Models of Colorectal Cancer

ONZEALD is currently being evaluated in a Phase 3 trial in patients with metastatic breast cancer and brain metastases

SAN DIEGO, May 23, 2019 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, taking a pr… […]

No Picture
News

Halozyme Announces argenx Has Selected Second Target Under ENHANZE® Technology Collaboration And License Agreement

– Triggers $10 million milestone payment to Halozyme in the second quarter –

SAN DIEGO, May 22, 2019 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today anno… […]